Article
Moderna ties up with Immatics to boost cancer vaccine development
Rating:
0.0
Views:
57
Likes:
1
Library:
1
Moderna said on Monday it has struck a deal with German drug developer Immatics for developing cancer vaccines and therapies, and would pay $120 million in cash and additional milestone payments.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value